Addex Therapeutics Ltd Earning Date (ADXN)

USA |NASDAQ |USD |ADR

ADXN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jun 30, 2022 (est) Mar 31, 2022 - $-0.83 $-0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jun 30, 2022 (est) Mar 31, 2022 - $397.49K $844.22K

Addex Therapeutics Ltd's next estimated earnings date (based on same quarter last year's date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.

ADXN Earnings Date & History Chart

ADXN Earnings Date & Revenue History

ADXN Earnings History

|
Show More
Show More

ADXN Revenue History

|
Show More
Show More

Addex Therapeutics Ltd Next Earnings Date & Report

ADXN Mar 2022 (FQ) Earnings Date & Report Preview

ADXN's next estimated earnings date (based on same quarter last year's report date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.

Addex Therapeutics Ltd Previous Earnings Dates & Reports

ADXN Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Addex Therapeutics Ltd's previous earnings date was Mar 10, 2022 for its fiscal quarter ended Dec 31, 2021.

ADXN's earnings per share (EPS) was $-0.83.

The EPS was lower than the previous fiscal quarter (Sep 2021) by 20.52%, and lower than the same period a year before (Dec 2020) by 896.88%.

Revenues were $397.49K, down by -41.72% from the previous quarter , and down by -78.17% from the same period last year.

The company reported a net income of $-4.42M.

Free cash flow for the quarter was $-2.97M , compared to $-2.54M last quarter and $656.76K a year before.

ADXN ended the quarter with $482.01K in total debt, a decrease of -7.52% compared to the previous quarter, and a decrease of -15.05% compared to the same quarter a year before.

ADXN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Addex Therapeutics Ltd's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.

ADXN's earnings per share (EPS) was $-1.78.

Revenues were $2.92M, down by -19.28% from previous year's revenue.

The company reported a net income of $-15.35M.

Addex Therapeutics Ltd reported a free cash flow of $-14.74M for its fiscal year, compared to $-12.24M a year ago.

The company ended the fiscal year with $482.01K in total debt, a decrease of -15.05% compared to the previous year.